Interleukin Genetics Announces Management and Board Ap...(45-8238 Weber Shandwick Rich Tauberma...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Interleukin Genetics Announces Management and Board Appointments
Date:9/6/2007
45-8238, Weber Shandwick
Rich Tauberman (201) 964-2408, Financial Relations Board
'/>"/>
| SOURCE Interleukin Genetics, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Wisconsin court affirms damages in Innogenetics, Abbott patent case
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. Symposium examines the effect of race on genetics and disease
4. Speaker announces business members of IT Task Force
5. Doyle announces technology tax credits for Berbee
6. Doyle announces new energy, global warming policies
7. Doyle announces $80M renewable energy strategy
8. GE announces first installation of Discovery VCT
9. UWM announces winners of RGI awards
10. Third Wave announces two senior management appointments
11. Mirus announces new method for making antibodies
Post Your Comments:
Breaking Biology Technology:Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4
[0] Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum[0] Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease[0] Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease[0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products
Other Biology Technology:UW paper in Science shows how some solids mimic liquids on nanoscale 2Rounding up gases, nano-style 2
Breaking Biology News(10 mins): Killer catfish? Venomous species surprisingly common, study finds 2Climate projections underestimate CO2 impact 2University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids 2Scientists Zero in on Brains Stopwatch 60001 1Adding Drug Doesnt Help Control Blood Pressure 59997 1Adding Drug Doesnt Help Control Blood Pressure 59997 2Buffalo neurologists investigate possible new underlying cause of MS 59993 1Buffalo neurologists investigate possible new underlying cause of MS 59993 2Buffalo neurologists investigate possible new underlying cause of MS 59993 3Buffalo neurologists investigate possible new underlying cause of MS 59993 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |